Literature DB >> 18537039

Effect of Terminalia arjuna on antioxidant defense system in cancer.

Nibha Verma1, Manjula Vinayak.   

Abstract

Constant production of reactive oxygen species (ROS) during aerobic metabolism is balanced by antioxidant defense system of an organism. Although low level of ROS is important for various physiological functions, its accumulation has been implicated in the pathogenesis of age-related diseases such as cancer and coronary heart disease and neurodegenerative disorders such as Alzheimer's disease. It is generally assumed that frequent consumption of phytochemicals derived from vegetables, fruits, tea and herbs may contribute to shift the balance towards an adequate antioxidant status. The present study is aimed to investigate the effect of aqueous extract of medicinal plant Terminalia arjuna on antioxidant defense system in lymphoma bearing AKR mice. Antioxidant action of T. arjuna is monitored by the activities of catalase, superoxide dismutase and glutathione S transferase which constitute major antioxidant defense system by scavenging ROS. These enzyme activities are low in lymphoma bearing mice indicating impaired antioxidant defense system. Oral administration of different doses of aqueous extract of T. arjuna causes significant elevation in the activities of catalase, superoxide dismutase and glutathione S transferase. T. arjuna is found to down regulate anaerobic metabolism by inhibiting the activity of lactate dehydrogenase in lymphoma bearing mice, which was elevated in untreated cancerous mice. The results indicate the antioxidant action of aqueous extract of T. arjuna, which may play a role in the anti carcinogenic activity by reducing the oxidative stress along with inhibition of anaerobic metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537039     DOI: 10.1007/s11033-008-9279-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

Review 1.  Invited review: manganese superoxide dismutase in disease.

Authors:  L A Macmillan-Crow; D L Cruthirds
Journal:  Free Radic Res       Date:  2001-04

Review 2.  Free radicals, antioxidant enzymes, and carcinogenesis.

Authors:  Y Sun
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

3.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Superoxide dismutase: improved assays and an assay applicable to acrylamide gels.

Authors:  C Beauchamp; I Fridovich
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

5.  Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart.

Authors:  K Gauthaman; M Maulik; R Kumari; S C Manchanda; A K Dinda; S K Maulik
Journal:  J Ethnopharmacol       Date:  2001-05       Impact factor: 4.360

6.  Severe impairment of antioxidant system in human hepatoma.

Authors:  R Corrocher; M Casaril; G Bellisola; G B Gabrielli; N Nicoli; G C Guidi; G De Sandre
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

7.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  Expression and prognostic significance of catalase in malignant mesothelioma.

Authors:  K Kahlos; Y Soini; R Sormunen; R Kaarteenaho-Wiik; P Pääkkö; K Linnainmaa; V L Kinnula
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

9.  Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer.

Authors:  Chandramani Pathak; Yogesh K Jaiswal; Manjula Vinayak
Journal:  Cancer Biol Ther       Date:  2007-10-08       Impact factor: 4.742

10.  Human copper-containing superoxide dismutase of high molecular weight.

Authors:  S L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  7 in total

1.  Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.

Authors:  Akhilendra Kumar Maurya; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2015-08-27       Impact factor: 2.316

2.  Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma.

Authors:  Xuesong Han; Tongzhang Zheng; Qing Lan; Yaqun Zhang; Briseis A Kilfoy; Qin Qin; Nathaniel Rothman; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Yawei Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

3.  Protective effect of Spirulina against 4-nitroquinoline-1-oxide induced toxicity.

Authors:  Vijaya Padma Viswanadha; Siddharth Sivan; Roopesh Rajendra Shenoi
Journal:  Mol Biol Rep       Date:  2010-03-30       Impact factor: 2.316

4.  Ellagic acid inhibits PKC signaling by improving antioxidant defense system in murine T cell lymphoma.

Authors:  Sudha Mishra; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2014-02-27       Impact factor: 2.316

5.  A low dose of doxorubicin improves antioxidant defence system and modulates anaerobic metabolism during the development of lymphoma.

Authors:  Nibha Verma; Manjula Vinayak
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

6.  In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease.

Authors:  Shereen K Ali; Ahmed R Hamed; Maha M Soltan; Usama M Hegazy; Esameldin E Elgorashi; Ibrahim A El-Garf; Ahmed A Hussein
Journal:  BMC Complement Altern Med       Date:  2013-05-30       Impact factor: 3.659

Review 7.  A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's Disease.

Authors:  Amir R Afshari; Hamid R Sadeghnia; Hamid Mollazadeh
Journal:  Adv Pharmacol Sci       Date:  2016-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.